Skip links

Press Release Articles and Insights

Premier Logo

Premier Research Acquires Camargo Pharmaceutical Services

MORRISVILLE, N.C., May 18, 2021 /PRNewswire/ — Premier Research announced today that it has acquired Camargo Pharmaceutical Services based in Cincinnati. Premier Research is a leading provider of strategic and regulatory advisory services as well as clinical development services to the biotechnology, specialty pharma, and medical device industry. Camargo is

Camargo Pharmaceutical Services Acquires Paidion Research

CINCINNATI, Mar. 2, 2021 /PRNewswire/ — Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, Inc., a global pediatric clinical research organization (CRO) based in Durham, N.C. The acquisition is the second in a continuing effort by Camargo to expand

Paidion Research News Release: Coronavirus Disease (COVID-19)

We are closely monitoring developments with respect to the Coronavirus Disease (COVID-19). First, and most importantly, is the safety of our team. We have enacted company-wide telecommuting protocols without disrupting our normal business operations. Throughout this pandemic, we are committed to providing the superior service

Paidion Team Commemorates May Clinical Trials Day

Did you know…the first clinical trial is believed to have taken place aboard the sailing ship HMS Salisbury in 1747?  Surgeon mate James Lind divided 12 men with scurvy into six pairs and experimented with different remedies. The pair treated with citrus fruits made an

YouTube Video Exemplifies Paidion Mission

Renee loves babies. Literally. It’s her job as a NICU nurse. She does everything she can to give them–and their families–the care and, most important of all, the hope they deserve. Just like us. Paidion Research, Inc. is in the tiny miracles business. We’re proud of all we do–assisting

Paidion CEO Participates in Study Published in Lancet

Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. The study aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures. Dr. Mangum co-authored this study which was published in

Paidion Names Roberson New VP of Clinical Research

Destrey Roberson was recently named Vice President of Clinical Operations of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered in Durham, NC, the innovative company provides its drug

Barry Mangum, PharmD, FCP, Named CEO

Barry Mangum, PharmD, FCP has been named CEO of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered on Leigh Farm Road in Durham, the innovative company provides its

New (RTP) CRO Focuses Exclusively on Pediatric Clinical Research

(RESEARCH TRIANGLE PARK, NC) Paidion Research, Inc., a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently opened for business. Headquartered on Leigh Farm Road in Durham, Paidion combines pediatric clinical pharmacology